IMS for OCT for Pharma
Reserach Use Only AI Models for 30+ Retinal Pathologies & 40+ Biomarkers for Pharma Studies
Free Trial without Calls
Explore Altris IMS
Explore the platform in a virtual demo or let us show it to you during the call
Free Trial
Virtual Demo
Altris IMS — Value for Pharmaceutical Professionals
✔️ Organize OCT data
✔️Access historical data
✔️Research Only AI Models
-
What ECPs think
-
"I am really happy with using Altris IMS in our research projects. And I was really impressed with the robustness of data."
-
Alisdair Buchanan
Optometry Owner
"Altris IMS has significantly enhanced the way we work with OCT scans"
-
Dr. Sundeep Kheterpal
Ophthalmic Surgeon
"We are very happy with the outstanding customer service and support."
-
Jeff Sciberras
Optometry Clinic Owner
"The introduction of OCT with Altris IMS has transformed my practice literally overnight. The integration was seamless and Altris customer support has been outstanding."
For Innovative Pharma
Accelerates patient triage for research workflows through automated eligibility screening
Supports the creation of customizable eligibility frameworks based on predefined criteria
Enables analysis of historical data to support the identification of potentially eligible patients
Optimizes clinical workflows through consistent, automated analysis
Establishes a Real-World Evidence (RWE)–ready AI database of detected imaging biomarkers
Supports the identification of patients who may be eligible for new therapies based on predefined criteria
Enables analysis of historical OCT data to support patient stratification and population insights
Provides aggregated, de-identified analytics on patient volumes for commercial and strategic planning
Builds a Real-World Evidence (RWE)–ready AI database of detected imaging biomarkers
Results in numbers
Our company was created in 2017 and we achieved many milestones since then
Let's talk
For Commercial Specialists
Support identification of patient cohorts based on OCT imaging characteristics, aligned with approved indications
Offer clear visualization and analysis of OCT imaging features across patient populations relevant to emerging treatment types
Enable retrospective analysis of OCT data from multiple manufacturers to support population-level insights
Provide access to aggregated real-world evidence (RWE) imaging data and longitudinal biomarker observations for analytical purposes
Support clinical workflows by assisting clinicians in the review, organization, and visualization of OCT imaging data.
For Clinical Researchers
Assist research teams in identifying potential study populations through OCT image analysis, in accordance with protocol-defined criteria
Support retrospective analysis of large volumes of OCT data from multiple manufacturers
Enable objective comparison of imaging-derived biomarkers across pre- and post-study timepoints for research and observational analysis
Configure study-specific filtering criteria to explore and query large OCT imaging datasets
Research
Running clinical studies shouldn’t be slowed down by manual processes or fragmented data
Contact Us- Supporting analysis of historical OCT data
- AI-enabled OCT image analysis
- Supporting protocol-defined patient review
- Supporting consistency and reproducibility
- Vendor-neutral OCT data access
- Supporting longitudinal imaging review
- Quantitative imaging outputs
Commercialization
Supporting transparency and data-driven insight across the drug commercialization process
Contact Us- Support clinical workflows by assisting users in reviewing and organizing OCT imaging data
- Support understanding of patient populations
- Deliver transparent, aggregated insights on patient cohorts d
- Enable access to de-identified, observational real-world data
- Support educational initiatives for ECPs
- Provide data-informed analytics to support pharmaceutical commercialization activities
Medical Director